GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Elevai Labs Inc (NAS:ELAB) » Definitions » PS Ratio

ELAB (Elevai Labs) PS Ratio : 0.09 (As of Dec. 14, 2024)


View and export this data going back to 2023. Start your Free Trial

What is Elevai Labs PS Ratio?

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Elevai Labs's share price is $2.29. Elevai Labs's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2024 was $26.51. Hence, Elevai Labs's PS Ratio for today is 0.09.

Good Sign:

Elevai Labs Inc stock PS Ratio (=0.08) is close to 2-year low of 0.08

The historical rank and industry rank for Elevai Labs's PS Ratio or its related term are showing as below:

ELAB' s PS Ratio Range Over the Past 10 Years
Min: 0.08   Med: 4.73   Max: 55.79
Current: 0.08

During the past 3 years, Elevai Labs's highest PS Ratio was 55.79. The lowest was 0.08. And the median was 4.73.

ELAB's PS Ratio is ranked better than
99.21% of 1015 companies
in the Biotechnology industry
Industry Median: 8.69 vs ELAB: 0.08

Elevai Labs's Revenue per Sharefor the three months ended in Sep. 2024 was $4.75. Its Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2024 was $26.51.

During the past 12 months, the average Revenue per Share Growth Rate of Elevai Labs was 99.80% per year.

Back to Basics: PS Ratio


Elevai Labs PS Ratio Historical Data

The historical data trend for Elevai Labs's PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Elevai Labs PS Ratio Chart

Elevai Labs Annual Data
Trend Dec21 Dec22 Dec23
PS Ratio
- - 11.53

Elevai Labs Quarterly Data
Dec21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only - 11.53 5.53 4.12 0.63

Competitive Comparison of Elevai Labs's PS Ratio

For the Biotechnology subindustry, Elevai Labs's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Elevai Labs's PS Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Elevai Labs's PS Ratio distribution charts can be found below:

* The bar in red indicates where Elevai Labs's PS Ratio falls into.



Elevai Labs PS Ratio Calculation

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.

Elevai Labs's PS Ratio for today is calculated as

PS Ratio=Share Price/Revenue per Share (TTM)
=2.29/26.51
=0.09

Elevai Labs's Share Price of today is $2.29.
Elevai Labs's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $26.51.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

PS Ratio=Market Cap/Revenue

The Revenue here is for the trailing 12 months.


Elevai Labs  (NAS:ELAB) PS Ratio Explanation

The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.

When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.

Similar to the PE Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PS Ratio measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.


Elevai Labs PS Ratio Related Terms

Thank you for viewing the detailed overview of Elevai Labs's PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Elevai Labs Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
120 Newport Center Drive, Suite. 250, Newport Beach, CA, USA, 92660
Elevai Labs Inc is a California-based physician-dispensed skincare company with a focus on modernizing aesthetic skincare. It has commercialized ELEVAI Exosomes a next-generation, patent-pending technology used in its ELEVAI flagship products.

Elevai Labs Headlines